Page 50 - 《南京医科大学学报》2026年第1期

第46卷第1期
· 44 · 南 京 医 科 大 学 学 报 2026年1月

Conflict of Interests： intelligence in breast cancer：a systematic review on PET
All authors declare no conflict of interests. imaging clinical applications［J］. Curr Med Imaging，
作者贡献声明： 2023，19（8）：832-843
卞雨蒙参与论文设计、论文撰写；丁紫藤和唐立钧参与 ［10］WU S G，WANG J，LIAN C L，et al. Evaluation of the 8th
文章修改和润色；李天女负责选题、论文修改、经费支持。 edition of the American joint committee on cancer’s path⁃
Author’s Contributions： ological staging system in prognosis assessment and treat⁃
BIAN Yumeng was involved in research design and thesis ment decision making for stage T1⁃2N1 breast cancer af⁃
writing；DING Ziteng and TANG Lijun were involved in article ter mastectomy［J］. Breast，2020，51：2-10
revision and polishing；LI Tiannü was responsible for topic selec⁃ ［11］SINGNURKAR A，POON R，METSER U. Head⁃to⁃head
tion，thesis revision，and financial support. comparison of the diagnostic performance of fdg pet/ct
［参考文献］ and fdg pet/MRI in patients with cancer：a systematic re⁃
view and meta⁃analysis［J］. AJR Am J Roentgenol，2024，
［1］ BRAY F，LAVERSANNE M，SUNG H，et al. Global cancer
223（3）：e2431519
statistics 2022：GLOBOCAN estimates of incidence and
［12］GRUENEISEN J，NAGARAJAH J，BUCHBENDER C，et
mortality worldwide for 36 cancers in 185 countries［J］.
al. Positron emission tomography/magnetic resonance im⁃
CA A Cancer J Clin，2024，74（3）：229-263
aging for local tumor staging in patients with primary
［2］ IACOB R，IACOB E R，STOICESCU E R，et al. Evaluat⁃
breast cancer：a comparison with positron emission tomog⁃
ing the role of breast ultrasound in early detection of
raphy/computed tomography and magnetic resonance im⁃
breast cancer in low⁃ and middle⁃income countries：a com⁃
aging［J］. Invest Radiol，2015，50（8）：505-513
prehensive narrative review［J］. Bioengineering，2024，11
［13］BOTSIKAS D，KALOVIDOURI A，BECKER M，et al.
（3）：262
Clinical utility of 18 F ⁃ FDG ⁃ PET/MR for preoperative
［3］ FOWLER A M，STRIGEL R M. Clinical advances in PET⁃
breast cancer staging［J］. Eur Radiol，2016，26（7）：2297-
MRI for breast cancer［J］. Lancet Oncol，2022，23（1）：
2307
e32-e43
［14］TO B，ISAAC D，ANDRECHEK E R. Studying lymphatic
［4］ ABU ABEELH E，ABUABEILEH Z. Comparative effec⁃
metastasis in breast cancer：current models，strategies，
tiveness of mammography，ultrasound，and MRI in the de⁃
and clinical perspectives［J］. J Mammary Gland Biol Neo⁃
tection of breast carcinoma in dense breast tissue：a sys⁃
plasia，2020，25（3）：191-203
tematic review［J］. Cureus，2024，16（4）：e59054
［15］MORAWITZ J，BRUCKMANN N M，DIETZEL F，et al.
［5］ SASAKI M，TOZAKI M，KUBOTA K，et al. Simultaneous
Comparison of nodal staging between CT，MRI，and［18F］⁃
18
whole⁃body and breast F⁃FDG PET/MRI examinations
FDG PET/MRI in patients with newly diagnosed breast
in patients with breast cancer：a comparison of apparent
cancer［J］. Eur J Nucl Med Mol Imag，2022，49（3）：992-
diffusion coefficients and maximum standardized uptake
1001
values［J］. Jpn J Radiol，2018，36（2）：122-133
［16］BRUCKMANN N M，KIRCHNER J，MORAWITZ J，et al.
［6］ LEITHNER D，HORVAT J V，BERNARD⁃DAVILA B，et
18
Prospective comparison of CT and F⁃FDG PET/MRI in
al. A multiparametric［（18）F］FDG PET/MRI diagnostic
N and M staging of primary breast cancer patients：initial
model including imaging biomarkers of the tumor and con⁃
results［J］. PLoS One，2021，16（12）：e0260804
tralateral healthy breast tissue aids breast cancer diagno⁃
［17］HAN S C，HUANG Y J. Comparison of the performance of
sis［J］. Eur J Nucl Med Mol Imaging，2019，46（9）：1878-
［（18）f］⁃fdg pet/ct and［（18）f］⁃fdg pet/MRI for lymph
1888
node metastasis in breast cancer：a systematic review and
［7］ ROMEO V，CLAUSER P，RASUL S，et al. AI⁃enhanced
meta⁃analysis［J］. Curr Med Imaging，2024，20：e1573405
18
simultaneous multiparametric F⁃FDG PET/MRI for accu⁃
6304849
rate breast cancer diagnosis［J］. Eur J Nucl Med Mol
［18］DE MOOIJ C M，SUNEN I，MITEA C，et al. Diagnostic
Imag，2022，49（2）：596-608
performance of PET/computed tomography versus PET/
［8］ ZHU H L，DOGAN B E. American joint committee on can⁃
MRI and diffusion⁃weighted imaging in the N⁃ and M⁃stag⁃
cer’s staging system for breast cancer，eighth edition：
ing of breast cancer patients［J］. Nucl Med Commun，
summary for clinicians［J］. Eur J Breast Health，2021，17
2020，41（10）：995-1004
（3）：234-238
［19］XIA L J，LAI J Q，HUANG D，et al. Comparing the diag⁃
［9］ ALONGI P，ROVERA G，STRACUZZI F，et al. Artificial
nostic efficacy of［（18）f］fdg pet/ct and［（18）f］fdg pet/